Business Wire

Sparrow Pharmaceuticals Announces First Patient Dosed in RESCUE, a Phase 2 Clinical Trial of SPI-62 for Cushing’s Syndrome

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, ...

enGene Holdings: A Potential Oncology Entrant

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...
Nasdaq

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 ...

MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it ...
West Hawaii Today

University of the Nations Kona looking to expand: Updated master plan proposes 62-acre addition

The University of the Nations Kona may soon be more than doubling in size. The organization cited increasing enrollment projections as the need for expansion. Currently, UofN Kona has approximately ...
Hosted on MSN

Bihar Phase 2 Polls: 47.62% voter turnout recorded till 1 pm

Bihar recorded a turnout of 47.62 per cent in the second phase of Assembly polls as of 1 pm, according to the data of the Election Commission of India. The highest voter turnout was recorded in ...